- Home
- / iNtRON Biotechnology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
iNtRON Biotechnology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩5.8 K
2024-10-29
Market Capitalization
₩192.7 B
2024-10-29
Revenue
₩6.4 B
FY, 2024
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 20.6B | 8.3B | 45.4B | 29.3B | 14.0B | 9.6B | 6.4B |
| Cost of goods sold | 2.0B | 3.2B | 11.7B | 4.9B | 1.9B | 2.6B | 1.5B |
| Gross profit | 22.3B | 9.0B | 41.4B | 24.5B | 12.3B | 7.3B | 5.0B |
| Gross profit margin, % | 108.6% | 107.6% | 91.2% | 83.7% | 87.9% | 75.8% | 78.5% |
| Operating expense total | 12.5B | 8.1B | 16.4B | 12.8B | 12.0B | 8.4B | 8.2B |
| Depreciation and amortization | 940.4M | 1.4B | 1.6B | 1.5B | 1.6B | 1.9B | 2.0B |
| EBITDA | 9.9B | 890.8M | 25.1B | 11.7B | 485.6M | (898.5M) | (3.3B) |
| EBITDA margin, % | 48.0% | 10.7% | 55.1% | 39.9% | 3.5% | -9.4% | -51.7% |
| EBIT | 7.3B | (1.9B) | 18.2B | 10.1B | (1.1B) | (8.6B) | (5.3B) |
| EBIT margin, % | 35.4% | -22.4% | 40.1% | 34.5% | -8.1% | -89.8% | -83.3% |
| Interest income | 225.9M | 785.3M | 435.7M | 424.4M | 1.7B | 2.5B | 1.3B |
| Interest expense | 152.6M | 957.1M | 1.2B | 1.6B | 3.5B | 2.9B | 23.4M |
| Pre tax profit | 7.3B | (1.9B) | 17.1B | 10.6B | 8.3B | (10.8B) | (3.0B) |
| Income tax expense | (1.4B) | 1.3B | 2.1B | 846.8M | 2.6B | (1.1B) | (414.7M) |
| Net Income | 8.7B | (3.2B) | 14.9B | 9.7B | 5.7B | (9.7B) | (2.6B) |